13.06.2016 14:04:56
|
DGAP-News: Emerging Capital Ltd Chess Depository Interests repr 1 sh
DGAP-News: Emerging Capital LIMITED (FSX:EDO): Information Regarding MYSY Limited - Product is Ready for Large-Scale Manufacturing.
With the raised capital and the large-scale production, MYSY expects, during the following three years, to have an income on the INTEGRA product alone of at least EUR 5 million.
At present, MYSY is in negotiations with a large wholesaler, who alone will guarantee the sales of at least EUR 15 million within a three year period, subject to large-scale production being accomplished.
About INTEGRA
INTEGRA is a "virtual syringe" product based on dermaphoresis technology that is a non-invasive medicinal delivery device that provides regenerative rehabilitation therapy with instant pain relief. The product carries the drug molecules, mixed with a gel carrier, into the body with the aid of the SYMPLY device.
For further information, please contact:
INVESTOR AND MEDIA RELATIONS =============================== LINDA KIRKLAND info@emergingcapitalltd.com www.emergingcapitalltd.com
ABOUT EMERGING CAPITAL LIMITED =============================== Emerging Capital Limited is listed on NSX, Australia with ticker symbol ECL and on Frankfurt, Germany with ticker symbol EDO.
The primary investment objective of the Company is to develop as an aggressive investment and transaction oriented business focused on wealth creation for its shareholders. The main investment activities of the Company are expected to focus on small to medium sized enterprises that are suitable for future listing on recognised stock exchanges and may require further working capital, development assistance and/or management to realize their respective potential.
---------------------------------------------------------------------------
13.06.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
---------------------------------------------------------------------------
471115 13.06.2016
DGAP-News: Emerging Capital Ltd. / Key word(s): Investment/Product Launch
EMERGING CAPITAL LIMITED (FSX:EDO): Information Regarding MYSY Limited -
Product is Ready for Large-Scale Manufacturing.
13.06.2016 / 14:04
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Emerging Capital Limited (FSX: EDO) ("Emerging") is pleased to announce,
MYSY Ltd. ("MYSY"), an innovative medical device company, of which Emerging
owns 50% of the shares, has successfully concluded compliance tests on
INTEGRA.
To take full advantage of the finished INTEGRA product, Emerging aims to
raise additional EUR 1,000,000 to begin large-scale production.
With the raised capital and the large-scale production, MYSY expects, during the following three years, to have an income on the INTEGRA product alone of at least EUR 5 million.
At present, MYSY is in negotiations with a large wholesaler, who alone will guarantee the sales of at least EUR 15 million within a three year period, subject to large-scale production being accomplished.
About INTEGRA
INTEGRA is a "virtual syringe" product based on dermaphoresis technology that is a non-invasive medicinal delivery device that provides regenerative rehabilitation therapy with instant pain relief. The product carries the drug molecules, mixed with a gel carrier, into the body with the aid of the SYMPLY device.
For further information, please contact:
INVESTOR AND MEDIA RELATIONS =============================== LINDA KIRKLAND info@emergingcapitalltd.com www.emergingcapitalltd.com
ABOUT EMERGING CAPITAL LIMITED =============================== Emerging Capital Limited is listed on NSX, Australia with ticker symbol ECL and on Frankfurt, Germany with ticker symbol EDO.
The primary investment objective of the Company is to develop as an aggressive investment and transaction oriented business focused on wealth creation for its shareholders. The main investment activities of the Company are expected to focus on small to medium sized enterprises that are suitable for future listing on recognised stock exchanges and may require further working capital, development assistance and/or management to realize their respective potential.
---------------------------------------------------------------------------
13.06.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
---------------------------------------------------------------------------
471115 13.06.2016

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Emerging Capital Ltd Chess Depository Interests repr 1 shmehr Nachrichten
Keine Nachrichten verfügbar. |